Wiegand G, Selleng K, Gründling M, Jack R S
Institut für Immunologie und Transfusionsmedizin, Klinikum der Universität Greifswald, Germany.
Mol Med. 1999 Mar;5(3):192-202.
Systemic inflammatory response syndrome (SIRS) is a mild inflammatory episode which, in a minority of patients, may deteriorate into septic shock. In the mouse, injection of bacteria or bacterial endotoxin induces systemic inflammation through the activation of blood monocytes, which leads to lethal shock. A number of intervention strategies have been shown to prevent progression to shock in mouse model systems. However, recent clinical trials of a number of these therapeutic strategies in patients have been uniformly disappointing. In contrast to the situation in the mouse models, there may be many different ways to initiate systemic inflammation in patients and not all of them need necessarily involve activation of blood monocytes. If there is no unifying mechanism behind the induction of systemic inflammation in patients and no common rules governing its development, then it is unlikely that generally applicable therapeutic strategies will be found that can prevent progression into shock.
We used differential display to compare gene expression patterns in monocytes of recent-admission multi-trauma patients with clinically diagnosed SIRS to the patterns in monocytes of healthy controls.
Of seven differentially displayed bands that were recovered and sequenced, five were associated with SIRS and two were preferentially expressed in the monocytes of healthy controls.
The data show that monocytes of SIRS patients are in an activation state that is different from that of monocytes from the healthy controls, that monocytes from many individual patients share similar patterns of differentially expressed sequences, and that by this criterion, the multi-trauma SIRS patients are a remarkably coherent group.
全身炎症反应综合征(SIRS)是一种轻度炎症发作,少数患者可能会恶化为感染性休克。在小鼠中,注射细菌或细菌内毒素会通过激活血液中的单核细胞诱导全身炎症,进而导致致命性休克。在小鼠模型系统中,已证明多种干预策略可预防休克进展。然而,最近在患者中对其中一些治疗策略进行的临床试验均令人失望。与小鼠模型的情况不同,在患者中引发全身炎症可能有多种不同方式,且并非所有方式都必然涉及血液单核细胞的激活。如果患者全身炎症诱导背后没有统一机制,且其发展没有共同规律,那么就不太可能找到能预防休克进展的普遍适用的治疗策略。
我们使用差异显示技术,比较近期入院的多发伤且临床诊断为SIRS患者的单核细胞与健康对照者单核细胞中的基因表达模式。
回收并测序的7条差异显示条带中,5条与SIRS相关,2条在健康对照者的单核细胞中优先表达。
数据表明,SIRS患者的单核细胞处于与健康对照者单核细胞不同的激活状态,许多个体患者的单核细胞具有相似的差异表达序列模式,并且据此标准,多发伤SIRS患者是一个高度一致的群体。